Losartan: In the Reduction of Stroke Risk in Patients with Hypertension and Left Ventricular Hypertrophy

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.3, Iss.5, 2003-01, pp. : 371-377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Losartan/Hydrochlorothiazide: A Review of its Use in the Treatment of Hypertension and for Stroke Risk Reduction in Patients with Hypertension and Left Ventricular Hypertrophy

By Keating Gillian M.

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1239-1265

Adis International

Access to resources Recommend Favorite

Losartan: A Review of its Use in Stroke Risk Reduction in Patients with Hypertension and Left Ventricular Hypertrophy

By Moen Marit D. Wagstaff Antona J.

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2657-2674

Adis International

Access to resources Recommend Favorite

Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

By Devereux Richard B Lyle Paulette A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2311-2320

Informa Healthcare

Access to resources Recommend Favorite

Losartan for LIFE in hypertension with left ventricular hypertrophy?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 1, 2003-01 ,pp. : 115-118

Informa Healthcare

Access to resources Recommend Favorite

Left Ventricular Hypertrophy in Hypertension

Heart Drug, Vol. 2, Iss. 5, 2003-01 ,pp. : 251-265

Karger

Access to resources Recommend Favorite